Home Cart Sign in  
Chemical Structure| 1443118-44-2 Chemical Structure| 1443118-44-2

Structure of ML337
CAS No.: 1443118-44-2

Chemical Structure| 1443118-44-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ML 337 is a selective negative allosteric modulator of mGlu3 with IC50 of 593 nM.

Synonyms: ML337

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ML337

CAS No. :1443118-44-2
Formula : C21H20FNO3
M.W : 353.39
SMILES Code : O=C(C1=CC=C(C#CC2=CC=C(OC)C=C2)C=C1F)N3C[C@H](O)CCC3
Synonyms :
ML337
MDL No. :MFCD27937770

Safety of ML337

Related Pathways of ML337

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02219685 Hepatitis C Virus Infection Phase 2 Completed - United States, Massachusetts ... More >> Boston, Massachusetts, United States Less <<
NCT02301936 Hepatitis C Virus Infection Phase 2 Completed - United States, Maryland ... More >> Lutherville, Maryland, United States Less <<
NCT02301936 - Completed - -
NCT01791205 - Completed - Italy ... More >> Reggio Calabria, Calabria, Italy, 89133 Napoli, Campania, Italy, 80131 Telese Terme, Campania, Italy, 82037 Bologna, Emilia-Romagna, Italy, 40138 Roma, Lazio, Italy, 00133 Roma, Lazio, Italy, 00152 Roma, Lazio, Italy, 00161 Roma, Lazio, Italy, 00189 Legnano, Lombardia, Italy, 20025 Milano, Lombardia, Italy, 20157 Milano, Lombardia, Italy, 20162 Monza, Lombardia, Italy, 20052 Pavia, Lombardia, Italy, 27100 Ancona, Marche, Italy, 60020 Jesi, Marche, Italy, 60035 Torino, Piemonte, Italy, 10126 Torino, Piemonte, Italy, 10128 Bari, Puglia, Italy, 70124 Martina Franca, Puglia, Italy, 74015 Sassari, Sardegna, Italy, 07100 Firenze, Toscana, Italy, 50139 Pisa, Toscana, Italy, 56100 Prato, Toscana, Italy, 59100 Siena, Toscana, Italy, 53100 Perugia, Umbria, Italy, 06122 Cona (Ferrara), Veneto, Italy, 44124 Padova, Veneto, Italy, 35128 Verona, Veneto, Italy, 37126 Less <<
NCT00455013 - Completed - -
NCT03036839 Chronic Hepatitis c Phase 2 Active, not recruiting February 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, New York James J. Peters Veterans Administration Medical Center Bronx, New York, United States, 10468 United States, Texas Methodist Healthcare Dallas - The Liver Institute Dallas, Texas, United States, 75203 Texas Liver Institute/American Research Corporation San Antonio, Texas, United States, 78215 United States, Washington University of Washington Seattle, Washington, United States, 98104 Belgium CUB Hopital Erasme Brussels, Belgium, 1070 Cliniques Universitaires UCL Saint-Luc Brussels, Belgium, 1200 Germany JWG-Universität Frankfurt Frankfurt, Germany, 60590 Universitatsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Ifi Studien und Projekt GmbH Hamburg, Germany, 20251 University of Leipzig Leipzig, Germany, 04109 Italy IRCCS Ospedale Casa Sollievo Della Soferrenza San Giovanni Rotondo, Foggia, Italy, 71013 Ospedale Santa Maria Annunziata Antella, Italy, 50011 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Italy, 20122 Azienda Ospedaliera Città della Salute e della Scienza di Torino Torino, Italy, 10126 Taiwan Changhua Christian Hospital Changhua, Taiwan, 500 Kaohsiung Medical University Hospital Kaohsiung, Taiwan, 807 Kaohsiung Chang Gung Memorial Hospital Kaohsiung, Taiwan, 83301 China Medical University Hospital Taichung, Taiwan, 40447 National Taiwan University Hospital Taipei, Taiwan, 10002 Less <<
NCT02243800 Rheumatoid Arthritis ... More >> Vitamin D Deficiency Less << Phase 3 Unknown August 2016 France ... More >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr Less <<
NCT01791205 - Completed - -
NCT02219685 - Completed - -
NCT00455013 Disorder Related to Renal Tran... More >>splantation Less << Phase 2 Completed - United States, California ... More >> Ucsf San Francisco, California, United States, 94143 United States, Colorado Denver Nephrology, Pc Denver, Colorado, United States, 80218 University Of Colorado Health Sciences Center Denver, Colorado, United States, 80262 United States, Georgia Medical College Of Georgia Augusta, Georgia, United States, 30912 United States, Illinois Northwestern University Feinberg School Of Medicine Chicago, Illinois, United States, 60611 United States, Michigan Henry Ford Hospital Detriot, Michigan, United States, 48202 United States, New York Albany Medical College Albany, New York, United States, 12208 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28203 United States, Ohio University Of Cincinnati Cincinnati, Ohio, United States, 45267 Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Italy Local Institution Bologna, Italy, 40138 Local Institution Brescia, Italy, 25123 Local Institution Padova, Italy, 35128 Local Institution Roma, Italy, 00168 Spain Local Institution Barcelona, Spain, 08907 Local Institution Sevilla, Spain, 41013 Less <<
NCT01714817 Lupus Nephritis Phase 3 Completed - -
NCT01714817 - Completed - -
NCT02868242 Hepatitis C Virus Infection Phase 2 Active, not recruiting February 2019 Egypt ... More >> National Cancer Institute, Cairo University Cairo, Egypt Less <<
NCT01987453 HCV Infection Phase 2 Completed - -
NCT02487030 Hepatitis C Virus Infection Phase 3 Completed - Egypt ... More >> Cairo, Egypt, 11559 Cairo, Egypt, 11796 Mansourah, Egypt Shibin Al Kawm, Egypt Less <<
NCT01938378 Adverse Effects in the Therape... More >>utic Use of Plasma Substitutes Less << Phase 4 Recruiting December 2020 United States, Alabama ... More >> Octapharma Research Site Recruiting Birmingham, Alabama, United States, 35233 United States, Georgia Octapharma Research Site Recruiting Atlanta, Georgia, United States, 30322 Contact: michael          United States, Louisiana Octapharma Research Site Recruiting New Orleans, Louisiana, United States, 70118 United States, Minnesota Octapharma Research Site Recruiting Minneapolis, Minnesota, United States, 55455 United States, Missouri Octapharma Research Site Recruiting Saint Louis, Missouri, United States, 63130 United States, North Carolina Octapharma Research Site Recruiting Durham, North Carolina, United States, 27710 Less <<
NCT02487030 - Completed - -
NCT03042520 - Recruiting September 2022 Korea, Democratic People's Rep... More >>ublic of Korea University Ansan Hospital Recruiting Ansan, Korea, Democratic People's Republic of Contact: Hyung Joon Yim          Asan Medical Center Recruiting Asan, Korea, Democratic People's Republic of Contact: Young-Suk Lim          Soon Chun Hyang University Hospital Bucheon. Recruiting Bucheon, Korea, Democratic People's Republic of Contact: Young Seok Kim          Dong-A University Hospital Recruiting Busan, Korea, Democratic People's Republic of Contact: Sang-Young Han          Inje University Busan Paik Hospital Recruiting Busan, Korea, Democratic People's Republic of Contact: Youn-Jae Lee          Kyungpook National University Hospital Recruiting Daegu, Korea, Democratic People's Republic of Contact: Won Young Tak          Gachon University Gil Hospital Recruiting Incheon, Korea, Democratic People's Republic of Contact: Ju-Hyun Kim          Pusan National University Hospital Recruiting Pusan, Korea, Democratic People's Republic of Contact: Heo Jeong          Korea University Guro Hospital Recruiting Seoul, Korea, Democratic People's Republic of Contact: Yoon Jun Kim          Samsung Medical Center Recruiting Seoul, Korea, Democratic People's Republic of Contact: Seung Woon Paik          Seoul National University Bundang Hosptial Recruiting Seoul, Korea, Democratic People's Republic of Contact: Sook-Hyang Jeong          Seoul National University Hospital Recruiting Seoul, Korea, Democratic People's Republic of Contact: Kwan Soo Byun          Seoul St. Mary's Hospital Recruiting Seoul, Korea, Democratic People's Republic of Contact: Seung-Kew Yoon          Severance Hospital Recruiting Seoul, Korea, Democratic People's Republic of Contact: Sang Hoon Ahn          Korea, Republic of Gangnam Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Kwan Sik Lee          Taiwan Changhua Christian Hospital Recruiting Changhua, Taiwan Contact: Yu-Chun Hsu          Kaohsiung Chang Gung Memorial Hospital Recruiting Kaohsiung, Taiwan Contact: Tsung-Hui Hu          Kaoshiung Medical University Hospital Recruiting Kaoshiung City, Taiwan Contact: Wan-Long Chuang    0975-356064    waloch@kmu.edu.tw    Keelung Chang Gung Memorial Hospital Recruiting Keelung, Taiwan Contact: Rong-Nan Chien          China Medical University Recruiting Taichung, Taiwan Contact: Cheng-Yuan Peng          Chi Mei Liouying Hospital Recruiting Tainan, Taiwan Contact: Chih-Chou Chen          MacKay Memorial Hospital Recruiting Taipei, Taiwan Contact: Horng-Yuan Wang          National Cheng Kung University Hospital Recruiting Taipei, Taiwan Contact: Ting-Tsung Chang          National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Jia-Horng Kao          Taipei Veterans General Hospital Recruiting Taipei, Taiwan Contact: Chi-Jen Chu          Linkou Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan Contact: I-Shyan Sheen Less <<
NCT02740335 Significant Bleeding Risk Phase 3 Recruiting June 2021 -
NCT02650024 Hepatitis C H... More >>uman Immunodeficiency Virus Less << Phase 4 Recruiting July 2020 United States, California ... More >> Ucsd Hnrp Recruiting San Diego, California, United States, 92103 Contact: Melanie Crescini, B.S.    619-543-5016    mscrescini@ucsd.edu Less <<
NCT01726517 Chronic Hepatitis C Virus Phase 2 Completed - United States, Texas ... More >> San Antonio, Texas, United States, 78215 Less <<
NCT01726517 - Completed - -
NCT02808715 - Completed - -
NCT02021656 Chronic HCV Infection Phase 3 Completed - -
NCT02472886 - Completed - -
NCT02452944 - Completed - -
NCT02472886 Hepatitis C Virus Infection Phase 3 Completed - Estonia ... More >> Tallinn, Estonia, 10167 Tartu, Estonia, 51014 Russian Federation Ekaterinburg, Russian Federation, 620102 Krasnoyarsk, Russian Federation, 660049 Moscow, Russian Federation, 105275 Moscow, Russian Federation, 107014 Moscow, Russian Federation, 111123 Moscow, Russian Federation, 115446 Moscow, Russian Federation, 117593 Moscow, Russian Federation, 119435 Moscow, Russian Federation, 119991 Moscow, Russian Federation, 125367 Moscow, Russian Federation, 127015 Moscow, Russian Federation, 129090 Moscow, Russian Federation, 129110 Samara, Russian Federation, 443063 St. Petersburg, Russian Federation, 190103 St.petersburg, Russian Federation, 194044 Stavropol, Russian Federation, 355017 Tyumen, Russian Federation, 625026 Less <<
NCT02600351 Hepatitis C Virus Infection Phase 3 Terminated(Due to lack of feas... More >>ibility of enrolling participants, the study was terminated early.) Less << - -
NCT02452944 Bladder Cancer Not Applicable Completed - -
NCT01987453 - Completed - -
NCT02457611 Hepatitis C Infection With HIV... More >> Co-Infection Less << Phase 2 Completed - Germany ... More >> Berlin, Germany Bonn, Germany Frankfurt am Main, Germany United Kingdom London, United Kingdom Less <<
NCT02600351 - Terminated(Due to lack of feas... More >>ibility of enrolling participants, the study was terminated early.) Less << - -
NCT02350569 Hepatitis C Virus Infection Phase 2 Completed - United States, California ... More >> San Francisco, California, United States United States, Illinois Chicago, Illinois, United States United States, Louisiana New Orleans, Louisiana, United States United States, Michigan Detroit, Michigan, United States United States, New York New York, New York, United States United States, Texas Dallas, Texas, United States Less <<
NCT02350569 - Completed - -
NCT02226549 - Completed - -
NCT01938430 Chronic HCV Infection Phase 2 Completed - -
NCT02457611 - Completed - -
NCT02010255 Chronic HCV Infection Phase 2 Completed - -
NCT02226549 Hepatitis C Virus Infection Phase 2 Completed - United States, Texas ... More >> San Antonio, Texas, United States Less <<
NCT01701401 Chronic Hepatitis C Virus Phase 3 Completed - -
NCT01768286 Chronic Hepatitis C Virus Phase 3 Completed - -
NCT02010255 - Completed - -
NCT01826981 - Completed - -
NCT01851330 Chronic Hepatitis C Virus Phase 3 Completed - -
NCT01768286 - Completed - -
NCT02738333 Hepatitis C Virus Infection Phase 3 Completed - Japan ... More >> Bunkyo, Japan Chiba, Japan Chuo City, Japan Ehime, Japan Fukuoka, Japan Fukuyama, Japan Gifu, Japan Ibaragi, Japan Ikeda, Japan Iruma-gun, Japan Itabashi, Japan Izunokuni, Japan Kagoshima, Japan Kashihara, Japan Kitakyushu, Japan Kumamoto, Japan Kyoto, Japan Maebashi, Japan Matsumoto, Japan Morioka, Japan Musashino, Japan Nagasaki, Japan Nagoya, Japan Nishinomiya, Japan Ogaki City, Japan Okayama, Japan Omura, Japan Osaka, Japan Sagamihara, Japan Saga, Japan Sapporo, Japan Sendai, Japan Suita, Japan Takamatsu, Japan Ube, Japan Yamagata, Japan Yufu, Japan Less <<
NCT01851330 - Completed - -
NCT02738333 - Completed - -
NCT01984294 Chronic HCV Infection Phase 2 Completed - United States, Texas ... More >> San Antonio, Texas, United States, 78215 Less <<
NCT01938430 - Completed - -
NCT01984294 - Completed - -
NCT02613871 Hepatitis C Virus Infection Phase 3 Completed - Taiwan ... More >> Changhua, Taiwan Chiayi City, Taiwan Kaohsiung City, Taiwan Kaohsiung, Taiwan Keelung, Taiwan Taichung, Taiwan Tainan City, Taiwan Tainan, Taiwan Taipei City, Taiwan Taipei, Taiwan Taoyuan, Taiwan Less <<
NCT02613871 - Completed - -
NCT01826981 Chronic Hepatitis C Phase 2 Completed - New Zealand ... More >> Auckland Clinical Studies Ltd. Auckland, New Zealand Christchurch Clinical Studies Trust Christchurch, New Zealand Less <<
NCT03776292 - Recruiting March 2019 Egypt ... More >> Mansoura faculty of Medicine- Mansoura Urology and nephrology center Recruiting Mansourah, Dakahlia, Egypt Contact: Mohamed A Ghanem, A.Professor    00201067883998    mohamed.abdel_latif@yahoo.com Less <<
NCT01924949 Hepatitis C Phase 2 Completed - United States, Massachusetts ... More >> Boston, Massachusetts, United States Less <<
NCT02081079 Chronic Genotype 4 HCV ... More >> Chronic Genotype 5 HCV Less << Phase 2 Completed - France ... More >> Clermont Ferrand, France, 63003 Clichy, France, 92110 Limoges, France, 87042 Toulouse, France, 31059 Villejuif, France, 94800 Less <<
NCT02081079 - Completed - -
NCT02202980 Chronic Hepatitis C Phase 2 Completed - New Zealand ... More >> Auckland, New Zealand Christchurch, New Zealand Less <<
NCT01701401 - Completed - -
NCT02251717 Hepatitis C Virus Infection Phase 2 Completed - Austria ... More >> Wien, Austria France Marseille, France Paris, France Germany Hannover, Germany Italy Milan, Italy Less <<
NCT02480387 Treatment of Hepatitis C Phase 2 Completed - United States, California ... More >> Peter J. Ruane, MD, Inc. Los Angeles, California, United States, 90036 Less <<
NCT01924949 - Completed - -
NCT02251717 - Completed - -
NCT02413593 Hepatitis C Virus Infection Phase 2 Completed - Canada, Alberta ... More >> Calgary, Alberta, Canada, T2N 4Z6 Edmonton, Alberta, Canada, T5H 4B9 Edmonton, Alberta, Canada, T6G 2B7 Canada, British Columbia Vancouver, British Columbia, Canada, V5Z 1H2 Vancouver, British Columbia, Canada, V5Z 1M9 Vancouver, British Columbia, Canada, V6Z 2K5 Canada, Ontario Brampton, Ontario, Canada, L6R 3J7 London, Ontario, Canada, N6A 5A5 Ottawa, Ontario, Canada, K1H 8L6 Toronto, Ontario, Canada, M5T 2S8 Toronto, Ontario, Canada, M6H 3M1 Vaughan, Ontario, Canada, L4L 4Y7 Canada, Quebec Montreal, Quebec, Canada, H2L 4P9 Montreal, Quebec, Canada, H2X 0A9 Canada Quebec, Canada, G1V 4G2 Less <<
NCT01975675 Chronic HCV Infection Phase 3 Completed - Japan ... More >> Ichikawa, Chiba, Japan, 272-8516 Kurume, Fukuoka, Japan, 830-0011 Ogaki, Gifu, Japan, 503-0864 Sapporo, Hokkaido, Japan, 060-8648 Nishinomiya, Hyogo, Japan, 663-8501 Matsumoto, Nagano, Japan, 390-8621 Omura, Nagasaki, Japan, 856-8562 Suita, Osaka, Japan, 565-0871 Izunokuni, Shizuoka, Japan, 410-2295 Chiyoda-ku, Tokyo, Japan, 101-8643 Itabashi-ku, Tokyo, Japan, 173-8610 Musashino, Tokyo, Japan, 180-8610 Shinjuku, Tokyo, Japan, 162-8566 Kofu, Yamanashi, Japan, 400-0027 Akita, Japan, 010-0933 Chiba, Japan, 260-0856 Gifu, Japan, 500-8513 Okayama, Japan, 700-8558 Yamagata, Japan, 990-9585 Less <<
NCT02202980 - Completed - -
NCT02869763 Alcohol Consumption ... More >> Healthy Less << Not Applicable Completed - Spain ... More >> Parc Salut Mar Barcelona, Spain, 08003 Less <<
NCT01975675 - Completed - -
NCT01965535 HCV Infection Phase 2 Completed - France ... More >> Clermont Ferrand, France, 63003 Clichy, France, 92110 Creteil, France, 94000 Grenoble, France, 38043 Lille, France, 57037 Limoges, France, 87042 Lyon, France, 69317 Marseille, France, 13285 Montpelier, France, 34295 Nancy, France, 54500 Nice, France, 06202 Paris, France, 75012 Paris, France, 75013 Paris, France, 75014 Paris, France, 75020 Pessac, France, 33604 Rennes, France, 35033 Strasbourg, France, 67091 Toulouse, France, 31059 Less <<
NCT02073656 - Completed - -
NCT02413593 - Completed - -
NCT01965535 - Completed - -
NCT02073656 Hepatitis C Virus ... More >> HIV Less << Phase 3 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.83mL

0.57mL

0.28mL

14.15mL

2.83mL

1.41mL

28.30mL

5.66mL

2.83mL

 

Historical Records

Categories